PLoS ONE (Jan 2015)

Correction: HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.

  • Young-Ho Lee,
  • Xiyong Liu,
  • Fuming Qiu,
  • Timothy R O'Connor,
  • Yun Yen,
  • David K Ann

DOI
https://doi.org/10.1371/journal.pone.0124853
Journal volume & issue
Vol. 10, no. 4
p. e0124853

Abstract

Read online

[This corrects the article DOI: 10.1371/journal.pone.0121207.].